Groundbreaking research shows how silencing the ß3 integrin gene using targeted nanoparticles can inhibit metastasis in triple-negative breast cancer by reversing EMT.
How collaborative open science challenges are transforming breast cancer prognosis through advanced predictive modeling and crowd-sourced innovation.